RenovaroCube completes acquisition of Cyclomics to advance cutting-edge cancer diagnostics
Acquiring Company
Renovaro
Acquired Company
Cyclomics
UtrechtBiotechnologyHealth CareArtificial IntelligenceMedicalMachine LearningHealth DiagnosticsGeneticsDescription
Renovaro Inc. (Nasdaq: RENB) has signed an agreement to acquire 100% ownership of Cyclomics, reinforcing their cutting-edge cancer diagnostics partnership. The acquisition reflects a shared commitment by Renovaro Inc. and Cyclomics to advancing state-of-the-art technologies in cancer diagnostics and treatment, positioning RenovaroCube to be a leader in early cancer diagnostics and monitoring of treatment efficacy.
Quick answer
Renovaro is acquiring Cyclomics, announced April 24, 2024.
- How much did Renovaro pay for Cyclomics?
- The deal value was not disclosed.
- What does Renovaro do?
- Renovaro Inc. is a trailblazer in AI-driven early cancer diagnostics and therapeutics.
- Where are Renovaro and Cyclomics based?
- Cyclomics is based in Utrecht, Utrecht, Netherlands.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Health Diagnostics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption (May 1, 2024)
- Eli Lilly and Company acquires manufacturing facility from Nexus Pharmaceuticals to expand U.S. capacity (April 22, 2024)
- Johnson & Johnson (J&J) completes $12.5 Billion Acquisition of Shockwave Medical to Strengthen Cardiac Health Solutions, $13B (April 5, 2024)
- Reverba completes acquisition of Six Degrees Worldwide Inc. to integrate medical communication services (April 3, 2024)
- KARL STORZ SE & Co. KG announces non-binding acquisition proposal and exclusivity arrangement with Asensus Surgical, Inc. (April 3, 2024)
- Juvisé Pharmaceuticals acquires rights to MS therapy Ponvory outside North America (April 2, 2024)
Who to call at Renovaro, and when
When Renovaro changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Renovaro raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Renovaro, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Renovaro. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Renovaro makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Cyclomics?
Cyclomics was acquired by Renovaro. The deal was reported on April 24, 2024. Renovaro Inc. is a trailblazer in AI-driven early cancer diagnostics and therapeutics. Renovaro is privately held and operates in Biotechnology.
When did Renovaro acquire Cyclomics?
Renovaro's acquisition of Cyclomics was reported on April 24, 2024. Renovaro Inc. (Nasdaq: RENB) has signed an agreement to acquire 100% ownership of Cyclomics, reinforcing their cutting-edge cancer diagnostics partnership. The acquisition reflects a shared commitment by Renovaro Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Cyclomics do?
Cyclomics is a leader in ultra-sensitive 4th generation multi-omics molecular biology. It is privately held, operating in Genetics, and is based in Utrecht.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.